Now Available for Public Comment: Notice of Proposed Rulemaking (NPRM) for FDAAA 801 and NIH Draft Reporting Policy for NIH-Funded Trials
Trial record 5 of 9 for:    AADCRC

OIT and Xolair® (Omalizumab) in Cow's Milk Allergy

This study is ongoing, but not recruiting participants.
Sponsor:
Collaborator:
Information provided by (Responsible Party):
Hugh.Sampson, Mount Sinai School of Medicine
ClinicalTrials.gov Identifier:
NCT01157117
First received: July 2, 2010
Last updated: May 2, 2013
Last verified: May 2013
No Study Results Posted on ClinicalTrials.gov for this Study
  Study Status: This study is ongoing, but not recruiting participants.
  Estimated Study Completion Date: July 2015
  Estimated Primary Completion Date: January 2015 (Final data collection date for primary outcome measure)